Letter to the editor: 'Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa'.

IF 2.7 3区 医学 Q2 PHARMACOLOGY & PHARMACY Expert Opinion on Emerging Drugs Pub Date : 2022-12-01 DOI:10.1080/14728214.2022.2152202
Anastasios Georgiadis, Alexander J Smith, Michel Michaelides, Stuart Naylor, Alexandria Forbes
{"title":"Letter to the editor: 'Emerging gene therapy products for <i>RPGR</i>-associated X-linked retinitis pigmentosa'.","authors":"Anastasios Georgiadis,&nbsp;Alexander J Smith,&nbsp;Michel Michaelides,&nbsp;Stuart Naylor,&nbsp;Alexandria Forbes","doi":"10.1080/14728214.2022.2152202","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12292,"journal":{"name":"Expert Opinion on Emerging Drugs","volume":"27 4","pages":"445-447"},"PeriodicalIF":2.7000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Emerging Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14728214.2022.2152202","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
致编辑的信:“rpcr相关x连锁视网膜色素变性的新兴基因治疗产品”。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
相关文献
Development of a Molecularly Stable Gene Therapy Vector for the Treatment of RPGR-Associated X-Linked Retinitis Pigmentosa.
IF 4.2 3区 医学Human gene therapyPub Date : 2019-08-01 DOI: 10.1089/hum.2018.244
Joseph C Giacalone, Jeaneen L Andorf, Qihong Zhang, Erin R Burnight, Dalyz Ochoa, Austin J Reutzel, Malia M Collins, Val C Sheffield, Robert F Mullins, Ian C Han, Edwin M Stone, Budd A Tucker
Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa.
IF 3.4 3区 医学Expert Opinion on Emerging DrugsPub Date : 2022-12-01 DOI: 10.1080/14728214.2022.2152003
Cristina Martinez-Fernandez de la Camara, Jasmina Cehajic-Kapetanovic, Robert E MacLaren
Response: 'letter to the editor: emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa'.
IF 3.4 3区 医学Expert Opinion on Emerging DrugsPub Date : 2022-12-01 DOI: 10.1080/14728214.2022.2152212
Cristina Martinez-Fernandez de la Camara, Jasmina Cehajic-Kapetanovic, Robert E MacLaren
来源期刊
CiteScore
5.90
自引率
0.00%
发文量
28
审稿时长
>12 weeks
期刊介绍: Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.
期刊最新文献
An update on emerging anti-amyloid-β monoclonal antibodies for treating Alzheimer's disease: the role of apolipoprotein E. Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder. Emerging treatments for sarcoma: from 2024 onward. Emerging biological treatments for asthma. Mitapivat: a step forward across different hemolytic diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1